CLOV vs FLGT · rev $1.37B vs rev $283.5M
Clover Health Investments Corp (CLOV) versus Fulgent Genetics Inc (FLGT) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Fulgent Genetics Inc (FLGT) is a diagnostics & research company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported FLGT revenue for 2024-12-31 was $283.5M. Net income was -$43.8M. Revenue was down 2.0% from 2023-12-31 to 2024-12-31. FLGT currently screens at market cap $586.6M.
CLOV currently screens at market cap $1.55B. FLGT currently screens at market cap $586.6M.
Not investment advice. Open the CLOV and FLGT stock pages for the full models.
Not investment advice.